Innovation Pharmaceuticals Inc (IPIX)

[FarmaZutical]

It's the first time in the company's history that a PR touting possible efficacy is accompanied by a word of caution:

"While impressed and optimistic about the initial feedback, Cellceutix needs to strongly caution that this is limited feedback from only the first patient in the trial and the initial results may not be durable for the patient or indicative of future outcomes in the study."

It suits CTIX well IMO and adds to the credibility which the CEO was running low of in the eye of the general market. I like it.